RD Lewis Holdings Inc. Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

RD Lewis Holdings Inc. acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 8,515 shares of the biotechnology company’s stock, valued at approximately $5,061,000. Axon Enterprise makes up approximately 5.8% of RD Lewis Holdings Inc.’s investment portfolio, making the stock its largest holding.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Asset Dedication LLC lifted its stake in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC increased its holdings in Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after purchasing an additional 20 shares during the last quarter. Venturi Wealth Management LLC increased its holdings in Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after purchasing an additional 21 shares during the last quarter. Insigneo Advisory Services LLC increased its holdings in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after purchasing an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC increased its holdings in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after purchasing an additional 24 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 0.3 %

Shares of Axon Enterprise stock opened at $554.82 on Tuesday. The firm has a market capitalization of $42.51 billion, a PE ratio of 143.36, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock’s fifty day moving average is $593.10 and its 200-day moving average is $538.04.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the transaction, the insider now directly owns 124,243 shares in the company, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on AXON. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. Finally, Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.